CLINICAL_TRIALS
trial_result
· 2016-03-10
Clinical Trial Update: A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization [Phase 2]
Summary
Phase 2 study evaluating intravenous sulopenem and oral PF-03709270 for hospitalized community-acquired pneumonia; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Pneumonia, Bacterial | Phase 2 | Status: COMPLETED | Results posted: 2016-03-10